Market Overview:
The global surgical fibrin formulation market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in surgical procedures. Based on type, the global surgical fibrin formulation market is segmented into natural and synthetic. The synthetic segment is expected to grow at a higher CAGR than the natural segment during the forecast period. This can be attributed to the increasing demand for advanced medical products and growing awareness about their benefits among consumers. Based on application, the global surgical fibrin formulation market is divided into hospital, clinic and emergency room, nursing home, and others segments. The hospital segment accounted for majority of share in 2017 owing to rising number of surgeries performed in hospitals across different regions worldwide. However, clinics are projected witness highest growth rate during forecast period due to increase in outpatient surgeries across developed countries such as UAS., Canada.
Product Definition:
Surgical Fibrin Formulation is a surgical adhesive used to attach tissue together or to close a wound. It is made up of fibrinogen and thrombin, which are proteins that form clots. When applied to tissue, the formulation forms a fibrin sealant that helps hold the tissue together and promotes healing.
Natural:
Natural fibrinogen is a protein that occurs in the body and is responsible for the clotting of blood. It helps maintain normal blood pressure by aiding coagulation (the process by which the liver produces proteins necessary for bleeding control). The natural form of fibrinogen has been used as an internal substitute to synthetic thrombin in clinical trials, however, it was found to be less effective than synthetic thrombin.
Synthetic:
Synthetic fibrinogen is a man-made product and has no relation to the natural form found in the body. It is manufactured by chemical synthesis of prothrombin complex with an aim to treat bleeding disorders such as hemophilia A and B. Synthetic fibrinogen can also be used in cases of severe hemorrhage due to its hemostatic properties which help maintain normal blood flow through the coagulation process.
Application Insights:
Based on application, the global surgical fibrin formulation market is segmented into hospital, clinic and emergency room, and other applications. The hospital segment dominated the overall application market in 2017 due to increasing prevalence of chronic diseases such as cancer and cardiac arrest that require surgeries for treatment. According to WHO in 2018, cancer is one of the leading causes of death worldwide with an estimated 1 billion people suffering from some form of it across the globe. Thus rising number of surgeries coupled with high demand for advanced healthcare services are factors contributing towards growth in this segment.
The others segment includes travel clinics, dental clinics, veterinary clinics among others which perform fewer procedures compared to hospitals or medical centers thus generating lower revenue than other segments owing to low penetration rate.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing R&D investments by manufacturers and growing demand for surgical fibrin dressings & adhesives in North America. The region is expected to maintain its position during the forecast period owing to high healthcare expenditure, rising geriatric population, and favorable reimbursement policies pertaining to suture materials used for wound closure.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure, economic development coupled with an increase in medical tourism activities supported by low cost of treatment as comparedto developed regions such as North America and Europe.
Key Companies Mentioned In This Report Include Baxter International; Johnson & Johnson Services Inc.
Growth Factors:
- Increasing incidence of chronic diseases: The global surgical fibrin formulation market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic disorders.
- Technological advancements: The development of novel technologies for surgical fibrin formulations is expected to drive the growth of this market during the forecast period. For instance, in 2017, Baxter International Inc., introduced a next-generation product called Fibrillar Collagen Matrix (FCM) that helps surgeons achieve hemostasis and improve patient outcomes.
- Rising demand for minimally invasive surgeries: Minimally invasive surgeries are gaining popularity due to their benefits such as shorter hospital stays, reduced pain and blood loss, and faster recovery times when compared with traditional open surgeries. This is driving the demand for surgical fibrin formulations which are used in these procedures as they help achieve hemostasis quickly and effectively without causing any damage to surrounding tissues or organs.
- Growing geriatric population: The global geriatric population is growing at a rapid pace owing to factors such as improved healthcare facilities and rising life expectancy rates across the world. This is leading to an increase in the number of patients requiring surgery for various age-related conditions such as joint replacement surgeries, cancer treatments, etc., thereby fueling the growth of the global surgical fibrin formulation market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Surgical Fibrin Formulation Market Research Report
By Type
Natural, Synthetic
By Application
Hospital, Clinic and Emergency Room, Nursing Home, Others
By Companies
Baxter International, CSL Behring, Johnson & Johnson, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, Tissuemed, Baxter International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Surgical Fibrin Formulation Market Report Segments:
The global Surgical Fibrin Formulation market is segmented on the basis of:
Types
Natural, Synthetic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic and Emergency Room, Nursing Home, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International
- CSL Behring
- Johnson & Johnson
- LifeBond
- Pharming Group
- Sea Run
- Shanghai RAAS
- Tissuemed
- Baxter International
Highlights of The Surgical Fibrin Formulation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natural
- Synthetic
- By Application:
- Hospital
- Clinic and Emergency Room
- Nursing Home
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Surgical Fibrin Formulation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Surgical fibrin formulation is a type of medical adhesive that is used to adhere tissue together during surgery. It is made up of small, fibrous pieces of protein that are bound together by natural blood proteins. This adhesive helps to keep the tissue attached as it heals, and can be used in a variety of surgical procedures.
Some of the major companies in the surgical fibrin formulation market are Baxter International, CSL Behring, Johnson & Johnson, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, Tissuemed, Baxter International.
The surgical fibrin formulation market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surgical Fibrin Formulation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Surgical Fibrin Formulation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Surgical Fibrin Formulation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Surgical Fibrin Formulation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Surgical Fibrin Formulation Market Size & Forecast, 2018-2028
4.5.1 Surgical Fibrin Formulation Market Size and Y-o-Y Growth
4.5.2 Surgical Fibrin Formulation Market Absolute $ Opportunity
Chapter 5 Global Surgical Fibrin Formulation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Surgical Fibrin Formulation Market Size Forecast by Type
5.2.1 Natural
5.2.2 Synthetic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Surgical Fibrin Formulation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Surgical Fibrin Formulation Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic and Emergency Room
6.2.3 Nursing Home
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Surgical Fibrin Formulation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Surgical Fibrin Formulation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Surgical Fibrin Formulation Analysis and Forecast
9.1 Introduction
9.2 North America Surgical Fibrin Formulation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Surgical Fibrin Formulation Market Size Forecast by Type
9.6.1 Natural
9.6.2 Synthetic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Surgical Fibrin Formulation Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic and Emergency Room
9.10.3 Nursing Home
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Surgical Fibrin Formulation Analysis and Forecast
10.1 Introduction
10.2 Europe Surgical Fibrin Formulation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Surgical Fibrin Formulation Market Size Forecast by Type
10.6.1 Natural
10.6.2 Synthetic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Surgical Fibrin Formulation Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic and Emergency Room
10.10.3 Nursing Home
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Surgical Fibrin Formulation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Surgical Fibrin Formulation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Surgical Fibrin Formulation Market Size Forecast by Type
11.6.1 Natural
11.6.2 Synthetic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Surgical Fibrin Formulation Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic and Emergency Room
11.10.3 Nursing Home
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Surgical Fibrin Formulation Analysis and Forecast
12.1 Introduction
12.2 Latin America Surgical Fibrin Formulation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Surgical Fibrin Formulation Market Size Forecast by Type
12.6.1 Natural
12.6.2 Synthetic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Surgical Fibrin Formulation Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic and Emergency Room
12.10.3 Nursing Home
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Surgical Fibrin Formulation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Surgical Fibrin Formulation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Surgical Fibrin Formulation Market Size Forecast by Type
13.6.1 Natural
13.6.2 Synthetic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Surgical Fibrin Formulation Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic and Emergency Room
13.10.3 Nursing Home
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Surgical Fibrin Formulation Market: Competitive Dashboard
14.2 Global Surgical Fibrin Formulation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter International
14.3.2 CSL Behring
14.3.3 Johnson & Johnson
14.3.4 LifeBond
14.3.5 Pharming Group
14.3.6 Sea Run
14.3.7 Shanghai RAAS
14.3.8 Tissuemed
14.3.9 Baxter International
